Epic Research provides daily market report in KLSE , Forex and Comex and gives update to help you make informed decision. It also gives advise about financial investment to achieve profitable returns by going long and short in market.

1. LY REPORTth JULY
Y O U R M I N T V I S O R Y
Page 1
Research Report 2nd sep. 2014
7 th july 2014
TOP GAINERS & LOSERS TOP GAINER % Change DIN042300721 2.50%
UZMA
10.45% DLADY 0.65%
DIN045801028
0.21% LAFMSIA 1.80%
KPS
11.11% AEONCR 0.97%
F&N
0.92% MYEG 5.02%
PESTECH
3.17% TOP LOSER % Change
BAT -1.02%
PETDAG
-2.99% NESTLE -0.85%
HLFG
-3.18% SOP -6.15%
TCHONG
-6.44% TAHPS -3.23%
LATITUD
-7.50% MPI -4.20%
PLENITU
-7.35% HLFG -1.04%
Olam International L...
-1.23% ComfortDelGro Corp L... -1.21%
Singapore Press Hold...
-0.94% CapitaMall Trust -0.75%
Noble Group Ltd
-0.69%
FTSE Bursa Malaysia KLCI
DIN042300721
UZMA
DLADY
DIN045801028
LAFMSIA
KPS
AEONCR
F&N
MYEG
PESTECH
% Change
2.50
10.4
0.65
0.21
1.80
11.1
0.97
0.92
5.02
3.17
0.00%
2.00%
4.00%
6.00%
8.00%
10.00%
12.00%
TOP GAINERS
BAT
PETDAG
NESTLE
HLFG
SOP
TCHONG
TAHPS
LATITUD
MPI
PLENITU
%Change
-1.02
-2.99
-0.85
-3.18
-6.15
-6.44
-3.23
-7.50
-4.20
-7.35
-8.00%
-7.00%
-6.00%
-5.00%
-4.00%
-3.00%
-2.00%
-1.00%
0.00%
TOP LOOSERSSnapshot For Bursa Malaysia KLCI (KLSE) Open 1,879.53 Previous Close 1,875.68 Day Range 1,866.11-1,879.53 Year-to- Date +2.00% 1-Year +11.54% 52-Week Range 1,702.57-1,896.23

2. LY REPORTth JULY
Y O U R M I N T V I S O R Y
Page 2
Research Report 2nd sep. 2014
7 th july 2014
MARKET UPDATES & STOCK RECOMMENDATION
Disclaimer
The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors
of fact or opinion. Users have the right to choose the product/s that suits them the most.
Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider
reliable.
This material is for personal information and based upon it & takes no responsibility
The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice.
Epic research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser.
Epic research shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of NSE and
BSE.
The share price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change
without notice. Analyst or any person related to epic research might be holding positions in the stocks recommended. It is understood that anyone who is browsing through
the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible
for . Any surfing and reading of the information is the acceptance of this disclaimer. All Rights Reserved.
Investment in equity & bullion market has its own risks.
We, however, do not vouch for the accuracy or the completeness thereof. We are not responsible for any loss incurred whatsoever for any financial profits or loss which
may arise from the recommendations above epic research does not purport to be an invitation or an offer to buy or sell any financial instrument. Our
Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone
which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken.
Give us a missed call at + Call: +6531581402 Visit us @ www.epicresearch.my
Public Bank Bhd and Public Islamic Bank Bhd have jointly
launched the “PB Step Up FD” campaign, which offers
promotional interest and profit rates of up to 3.80 per
cent per year.
Pharmaceutical company InQpharm Group Sdn Bhd is
confident of contributing significantly to
Malaysia’s biotechnology sector. InQpharm managing
director Ewoud Bos said Malaysia has a large talent pool
of life sciences graduates while the business
environment is also conducive for biotechnology
innovation.
Semen Indonesia has earmarked up to US$150 million
(RM472 million) to acquire cement companies in
Vietnam, Myanmar and Bangladesh. “Currently, we’re
assessing one company in Myanmar, since that company
also owns a coal mine. We estimate that it will cost
around US$30 million,” said president director Dwi
Soetjipto, here, on Wednesday, without disclosing the
name of the cement company in question.
At least 10 Swiss banks have withdrawn from a United
States programme aimed at settling a tax dispute
between them and the US, Swiss newspaper NZZ am
Sonntag said yesterday, quoting unnamed lawyers and
auditors.
PUBLIC BANK
BUY PUBLIC BANK ABOVE 19.350 TG 19.500, 19.700,
20.000 SL 19.150